| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| Torososide A; Torososide A | CFN97807 | 165689-32-7 | C38H32O15 = 728.66 | 5mg | QQ客服：2056216494 |
| 决明蒽醌； 美决明子素; Obtusifolin | CFN90394 | 477-85-0 | C16H12O5 = 284.27 | 20mg | QQ客服：2056216494 |
| 芦荟素B; Aloin B | CFN90434 | 28371-16-6 | C21H22O9 = 418.39 | 20mg | QQ客服：2159513211 |
| 1,5,7'-联大黄素甲醚; Floribundone 1 | CFN97845 | 118555-84-3 | C32H22O10 = 566.52 | 5mg | QQ客服：215959384 |
| 洋地黄蒽醌; Digitolutein | CFN92109 | 477-86-1 | C16H12O4 = 268.3 | 5mg | QQ客服：3257982914 |
| 2-羟甲基蒽醌; 2-(Hydroxymethyl)anthraquinone | CFN92110 | 17241-59-7 | C15H10O3 = 238.2 | 5mg | QQ客服：1413575084 |
| 茜素-1-甲醚; 2-Hydroxy-1-methoxyanthraquinone | CFN92111 | 6170-06-5 | C15H10O4 = 254.2 | 10mg | QQ客服：1457312923 |
| 2-羟基-3-羟甲基蒽醌 ; 2-Hydroxy-3-(hydroxymethyl)anthraquinone | CFN92112 | 68243-30-1 | C15H10O4 = 254.2 | 5mg | QQ客服：2056216494 |
| 竹红菌甲素; Hypocrellin A | CFN92439 | 77029-83-5 | C30H26O10 = 546.5 | 5mg | QQ客服：1457312923 |
| 竹红菌乙素; Hypocrellin B | CFN92440 | 123940-54-5 | C30H26O10 = 546.5 | 5mg | QQ客服：2056216494 |
| 竹红菌丙素; Hypocrellin C | CFN92441 | 149457-83-0 | C30H24O9 = 528.5 | 5mg | QQ客服：2159513211 |
| 锈色洋地黄醌醇; Digiferruginol | CFN92536 | 24094-45-9 | C15H10O4 = 254.2 | 5mg | QQ客服：1413575084 |
| 蒽醌-2-羧酸; 2-Anthraquinonecarboxylic acid | CFN92537 | 117-78-2 | C15H8O4 = 252.2 | 20mg | QQ客服：1457312923 |
| 9,10-Anthracenedione; 9,10-Anthracenedione | CFN92557 | 19852-76-7 | C16H12O5 = 284.3 | 5mg | QQ客服：3257982914 |
| 1,2-二羟基-3-甲基蒽醌; 1,2-dihydroxy-3-methyl-anthracene-9,10-dione | CFN92558 | 602-63-1 | C15H10O4 = 254.2 | 5mg | QQ客服：1413575084 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)